Search Results 611-620 of 17296 for egfr

1. A Study of SC-006 in Subjects With Advanced Cancer - Mayo Clinic

   5× ULN or estimated filtration rate (eGFR) ≥0 mL/min/1.73m2(using MDRD [Modification of Diet in Renal Disease] formula);; Serum albumin ≥ g/dL;; Amylase and ...

2. Safety of MT-401-OTS in Patients with Relapsed AML or MDS - Mayo Clinic

   eGFR ≥ 40 mL/min by the MDRD formula; LVEF ≥ 45% (prior to apheresis and lymphodepletion) Sex. Women of childbearing potential are eligible to participate ...

3. A Study to Evaluate the Safety and Effectiveness of Felzartamab in IgA Nephropathy - Mayo Clinic

   Rapidly progressive variant of IgAN, defined as eGFR loss by more than 30% per 3 months and not explained by changes in renin angiotensin system (RAS) blockade.

4. A Study To Evaluate The Effectiveness And Safety Of Panzyga In Patients With Chronic Lymphocytic Leukemia - Mayo Clinic

   Severe kidney disease (as defined by estimated glomerular filtration rate [eGFR] 140 kg. Eastern Cooperative Oncology Group (ECOG) performance score of ≥ 1 ...

5. Preoperative Antibiotic PNL Study - Mayo Clinic

   eGFR < 60 mL/min/1.73 m2; Cirrhosis and/or hepatitis; Pregnancy; Positive preoperative urine culture within 3 months; History of temperature ≥ 38.3 C ...

6. Laminar LAAX Pivotal IDE Study - Mayo Clinic

   Renal insufficiency, defined as estimated glomerular filtration rate (eGFR) \<30 mL/min/1.73 m2 or patients with end stage renal disease who are dialysis ...

7. Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia - Mayo Clinic

   Serum creatinine < 1.5 x institutional ULN or an estimated glomerular filtration rate (eGFR) of > 50 ml/min as calculated by the Modification of Diet in Renal ...

8. Study Of Safety And Efficacy Of Dapagliflozin + Metformin XR Versus Metformin XR In Participants With HR+, HER2-, Advanced Breast Cancer While On Treatment With Alpelisib And Fulvestrant - Mayo Clinic

   Moderate to severe renal impairment (e.g., estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73m^2 ). Participant has impairment of gastrointestinal ...

9. A Study to Evaluate Immunotherapy for Non-Small Cell Lung Cancer - Mayo Clinic

   NSCLC expressing epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), B-Raf proto-oncogene (BRAF) or ROS proto-oncogene 1 (ROS1) ...

10. A Study of PY314 in Subjects With Advanced Solid Tumors - Mayo Clinic

    Subject is a candidate for molecularly targeted therapy (e.g., drugs targeting EGFR, VEGF, ALK, ROS-1, NTRK, MET, RET and BRAF V600E, HER2). Applies to ...